莱纳利多米德在多发性骨髓瘤中的使用 (评论)
Chao-Wei Zhang1, Ya-Nan Wang1, Xue-Ling Ge1
1Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China.
Molecular and clinical oncology
|December 21, 2023
概括
列纳利多米德是多发性骨髓瘤 (MM) 的关键治疗方法,具有免疫调节和直接杀死细胞的作用. 基于莱纳利多米德的疗法,与其他药物结合或用于维护,显示有效性,但需要仔细监测副作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 多发性骨髓瘤 (MM) 是一种血液性恶性瘤.
- 列纳利多米德是MM治疗的关键第二代免疫调节药物.
研究的目的:
- 审查lenalidomide的药理性质和药理动力学.
- 评估基于莱纳利多米德的治疗方法在MM中的疗效和安全性.
主要方法:
- 临床试验和真实世界的研究对lenalidomide和基于lenalidomide的疗法的审查.
- 检查lenalidomide的作用机制,包括对VEGF,IL-6和亡途径的影响.
主要成果:
- 莱纳利多米德单独或结合使用 (例如与德克萨梅他松,博尔特佐米布,伊克萨佐米布,卡菲尔佐米布,达拉图穆马布),显著缓解了MM.
- 在移植后或非移植环境中使用莱纳利多米德的维持疗法可以改善结果.
- 其他药物,如ixazomib和carfilzomib提供好处,但具有特定的毒性 (心血管事件,神经病变,感染) 需要管理.
结论:
- 列纳利多米德是MM的基石疗法,具有多样化的应用和确定的疗效.
- 基于莱纳利多米德的疗法提供治疗益处,但对药物相互作用和患者特异性毒性进行仔细考虑对于最佳的临床应用至关重要.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
168
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
168
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


